Leerink Partners analyst Faisal Khurshid has maintained their bullish stance on PLRX stock, giving a Buy rating on September 13. Faisal ...

Pliant Therapeutics' stock has seen declines due to concerns with trial results and competition. Read what could be next for ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target ...

Carrie Coon, Elizabeth Olsen, and Natasha Lyonne play three sisters watching over their dying father in Azazel Jacobs’s drama ...

Check the time stamp on this data. Updated AI-Generated Signals for Pliant Therapeutics Inc. (PLRX) available here: PLRX.

Pliant Therapeutics Inc (PLRX) stock saw a modest uptick, ending the day at $12.6 which represents a slight increase of $0.73 or 6.15% from the prior close of $11.87. The stock opened at $12.18 and ...

After weeks of deliberation, Russia started a counteroffensive in Kursk. The Ukrainian incursion into that oblast, brilliant ...

From beef Wellington to a full English, Gordon Ramsay's favorite dishes run the gamut of classic comfort foods, delightful ...

Parking is available in Lot W1, directly adjacent to the building (you may park in spots designate “permit parking only).

Piper Sandler重申了对Pliant Therapeutics (NASDAQ: PLRX)股票的"增持"评级，维持40.00美元的目标价。 这一评级是在Boehringer Ingelheim最近宣布其Phase 3 FIBRONEER-IPF试验达到主要终点后做出的。

Former Australian Council of Trade Unions secretary Bill Kelty has reappeared on the public stage amid a developing political ...

周一，Leerink Partners 对 Pliant Therapeutics (NASDAQ:PLRX) 启动了覆盖，给予该股票"跑赢大盘"评级，目标价为 33.00 美元。这一评级基于该公司领先药物候选 bexotegrast 在特发性肺纤维化 (IPF) 治疗方面的潜力。 Bexotegrast（也称为 bexo）是一种整合素抑制剂，目前正在进行 Phase 2b BEACONIPF 研 ...